ProtectHealth Logo SVG
Find / Register

Measles Rubella Supplementary Immunisation Activity (MR SIA)​

According to the World Health Organization (WHO), an estimated 107,500 measles-related deaths occurred globally in 2023, with the majority being unvaccinated children under the age of five. Alarmingly, the proportion of children receiving the first dose of the measles vaccine in 2023 declined by 3% compared to 2019, highlighting the urgent need for renewed immunisation efforts. In response, the Ministry of Health (MOH) has decided to implement the Nationwide Measles Rubella Supplementary Immunization Activity (MR SIA) in 2025 to prevent outbreaks of this disease in Malaysia.

The Measles-Rubella Supplementary Immunisation Activity (MR SIA) is a special vaccination campaign designed to provide additional protection to children aged 6 months to 59 months against measles and rubella. This initiative ensures that all children receive at least one dose of the measles-rubella vaccine, significantly reducing the risk of outbreaks in Malaysia.​

ProtectHealth Corporation remains steadfast in its commitment to supporting the Ministry of Health (MOH) in achieving critical public health goals, particularly in disease prevention. As the primary administrator for the outsourcing of this vaccination programme, ProtectHealth aims to collaborate closely with private medical practitioners (PMPs) nationwide to ensure comprehensive coverage and the successful implementation of this vital initiative. Together, we can safeguard the health of our children and communities.

Objective

Interrupt Transmission of Measles and Rubella​

Increase Immunization Coverage

Achieve Measles & Rubella Elimination Goals

Strengthen Routine Immunization Systems

Support Surveillance and Monitoring

Info for Public

How Measles Rubella Supplementary Immunisation Activity (MR SIA) Works

What is Measles Rubella Supplementary Immunisation Activity (MRSIA)?

MR SIA is a special vaccination campaign aimed at providing additional protection to children against measles and rubella, both of which can cause serious health problems. Even if your child has already received their routine vaccinations, the MR SIA campaign is a way to ensure that no child is left unprotected.
Click Here

Frequently Asked Question (FAQ)

This section provides clear and concise answers to commonly asked questions about the Measles Rubella Supplementary Immunisation Activity (MRSIA).
Click Here

Info for Private Medical Practicioners (PMPs)

Why Join Us?

  • To strengthen community immunization coverage and prevent potential measles and rubella outbreaks across the country. 
  • To enhance public access to this initiative. 
  • To establish public private partnership in public health initiatives. 

How To Join?

Come and join us for the upcoming Engagement Session on 23rd April 2025.

To secure your spot, kindly RSVP by 18th April 2025 here: 

RSVP

Contact Us

03 – 8687 2525
[email protected]​
www.protecthealth.com.my​

Sentiasa berhubung dan dapatkan maklumat terkini mengenai kami.

Suka, ikuti dan kongsi akaun media sosial rasmi kami.

Ditubuhkan Di Bawah

Rakan Strategik Kami

Hak Cipta Terpelihara © 2024 - ProtectHealth Corporation Sdn. Bhd. (201601041792 / 1212734-T) (Ditubuhkan di bawah Kementerian Kesihatan)

PENAFIAN: ProtectHealth Corporation Sdn. Bhd. tidak akan bertanggungjawab atas kehilangan atau kerosakan yang disebabkan oleh penggunaan maklumat yang diperoleh dari laman webini.

How Does MR SIA Works?

  • Mass Vaccination Campaign: The Measles Rubella Supplementary Immunisation Activity campaign runs for continuously a few weeks at multiple locations aiming to achieve mass vaccination.
  • Convenient Vaccination Sites: To make it easy for parents, vaccination sites are set up in places like private health clinics and government Klinik Kesihatan.
  • Walk in and Prior Appointment are Welcome: Parents can make an appointment via MySejahtera mobile application, or You can just walk in with your child to the nearest vaccination site.
  • Safe and Free Vaccination: The Measles Rubella vaccine is safe and effective, with possible common side effects such as a small fever or a sore arm, which goes away quickly. It is also FREE under this campaign. 
What is the Measles and Rubella Vaccine?

The Measles and Rubella (MR) Vaccine is a live, attenuated vaccine designed to immunize against measles and rubella viruses. It is prepared using the Edmonston-Zagreb measles virus and Wistar RA 27/3 rubella virus strains, both propagated on human diploid cells (HDC).

Who can be given Measles and Rubella Vaccine Live, Attenuated (Freeze-Dried)?

The vaccine is recommended for active immunization against measles and rubella in infants, children, adolescents and young adult. The use of this vaccine should be in accordance with the recommendations by the Ministry of Health Malaysia. 

Who can’t be given Measles and Rubella Vaccine Live, Attenuated (Freeze-Dried)?

The MR vaccine should not be given to individuals: 

  • On corticosteroids, other immuno-suppressive drugs, or undergoing radiotherapy 
  • With febrile states and acute infectious diseases 
  • With leukaemia, severe anaemia, and other severe diseases of the blood system 
  • With severe impairment of renal function or decompensated heart diseases 
  • Who have recently received gammaglobulin or blood transfusions 
  • With potential allergies to vaccine components, including those with a history of anaphylactic or anaphylactoid reactions to neomycin or allergic to cow’s milk 

Check Skim Perubatan MADANI Eligibility

Find Skim Perubatan MADANI Clinics

Register My Clinic for Skim Perubatan MADANI

Check PeKa B40 Eligibility

Find PeKa B40 Clinics

Register My Clinic for PeKa B40

Find MR SIA Clinics